Brain and Behavior, 2012 · DOI: 10.1002/brb3.39 · Published: January 3, 2012
This research investigates the role of Glycoprotein nonmetastatic melanoma B (Gpnmb) in the central nervous system of rats, both under normal conditions and when inflammation is present. Gpnmb is a protein that is highly expressed in glioblastoma cells and is considered a potential therapeutic target. The study found that Gpnmb mRNA is present in various regions of the rat brain and spinal cord. Furthermore, Gpnmb protein was found in specific cells within these regions, particularly in microglia and macrophages. These cells are involved in immune and inflammatory responses within the brain. The research also showed that when the rats were exposed to a bacterial endotoxin (LPS) to induce inflammation, there was an increase in the number of Gpnmb-expressing microglia and macrophages in a specific brain region called the area postrema. This suggests that Gpnmb plays a role in regulating immune and inflammatory responses in the brain.
Gpnmb-targeted therapies may have detrimental effects on microglia/macrophage and radial glial lineage cells.
Gpnmb may serve as a novel regulator of immune/inflammatory responses in CNS.
Further studies are needed to clarify the role of Gpnmb in immune/inflammatory responses underlying traumatic nerve injury and neurodegenerative diseases